Pakistan Pharmaceutical Manufacturing Association

What Pakistan Pharmaceutical Manufacturing Association does

Pakistan Pharmaceutical Manufacturing Association (PPMA) is a non-profit trade association established on January 26, 1961 and registered on July 18, 1961 as the sole representative body for licensed pharmaceutical manufacturers in Pakistan. Headquartered in Islamabad, PPMA serves as the collective industry voice for domestic pharmaceutical manufacturers, advocating on policy, regulatory, and trade matters with the Drug Regulatory Authority of Pakistan (DRAP), the federal government, and international counterparts. Its membership comprises licensed pharmaceutical manufacturing companies operating across Pakistan's north and south zones, organized under a Central Executive Committee.

PPMA's core activities are non-commercial: policy advocacy, regulatory compliance support, capacity building, training, and the organization of industry events including the Pakistan Pharma Summit and International Pharma Convention. It collaborates closely with DRAP on drug pricing, serialization and traceability, and with Pharma Bureau on joint proposals to government authorities. Internationally, PPMA has facilitated partnerships with the Embassy of Pakistan in Beijing and CODA to engage 40+ Chinese biopharma, API, and medical device firms, and supported the Pak-Egypt Health Corridor with fast-track pharmaceutical certifications.

PPMA does not sell products or services and operates on a non-disclosed membership-fee basis. Its 11-50 staff support governance, advocacy, and event functions. The current leadership cycle (2024-26) is led by Chairman Tauqeer Ul Haq, Senior Vice Chairman Shafiq Ahmed Abbasi, and Vice Chairman Aman Ullah Sheikh, with Secretary General Nawaz Ahmed overseeing administration. No technology products, APIs, or proprietary platforms are offered; the association's value is institutional and representational rather than technological.

Name

Pakistan Pharmaceutical Manufacturing Association

Legal name

Pakistan Pharmaceutical Manufacturers Association

Website

https://ppma.org.pk

Company type

Private

Founded year

1961

Operating status

Operating

Headcount range

11–50 employees

Short description

PPMA is the non-profit trade association established in 1961 that exclusively represents licensed pharmaceutical manufacturers in Pakistan, providing policy advocacy, regulatory collaboration with DRAP, and industry events from its Islamabad headquarters.

Ownership category

akta.pro rank

Headquarters

HQ city

Islamabad

HQ country

Pakistan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Distribution channels1 record

Marketing channels7 records

Core offering

PPMA is a non-profit trade association founded in 1961 and headquartered in Islamabad that represents licensed pharmaceutical manufacturers in Pakistan. Its core activity is collective industry representation: advocating with government and regulators, providing a platform for member networking, organizing industry events and training, and publishing information relevant to the pharmaceutical manufacturing sector.

Product overview

PPMA is a trade association representing licensed pharmaceutical manufacturers across Pakistan. It does not offer products or services in the traditional sense, but rather serves as a collective voice for the pharmaceutical industry, providing advocacy, policy shaping, networking events, and industry collaboration. The association organizes events such as the Pakistan Pharma Summit, International Pharma Convention, and various CEC meetings, while also sharing industry news, blogs on health topics, and facilitating partnerships with international bodies like WHO, FDA, and EMA.

Differentiator

Problem solved

Functional benefit

Products and services

• Industry Advocacy and Regulatory Representation Collective representation of licensed pharmaceutical manufacturers before government, regulators, and external bodies; the core membership benefit of PPMA.
• Industry Conferences and Seminars Events and seminars for pharmaceutical manufacturers, providing networking, professional development, and sector intelligence to members.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Five partnerships are on record, tiered core.

• Embassy of Pakistan in BeijingcoreStrategic or Co-development PartnerThe Embassy of Pakistan in Beijing collaborated with CODA to mobilize over 40 leading Chinese Biopharma, API, and Medical Device giants for the 6th Pakistan-China B2B Investment Conference in Karachi (July 17-18). This strategic collaboration aims to drive advanced technology transfers and boost localized production in Pakistan with focus on vaccines, biologics, and generic APIs.
• Egyptian Health AuthoritiescoreStrategic or Co-development PartnerPakistan and Egypt established fast-track pharmaceutical certifications to eliminate regulatory delays, drastically accelerating bilateral medicine exports and expanding healthcare product reach across South Asia and Africa.
• Drug Regulatory Authority of Pakistan (DRAP)coreStrategic or Co-development PartnerPPMA works closely with DRAP on regulatory compliance, drug pricing policy, serialization and traceability implementation, and industry capacity building programs.
• Pharma BureaucoreStrategic or Co-development PartnerPPMA and Pharma Bureau collaborate on joint proposals to submit to government authorities regarding drug pricing, regulatory reforms, and industry policy matters.
• CODA (China)coreStrategic or Co-development PartnerCODA collaborated with the Embassy of Pakistan in Beijing to mobilize 40+ Chinese Biopharma companies for the Pakistan-China B2B Investment Conference, facilitating technology transfers and localized production in Pakistan.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Pharmaceutical Manufacturers Association of Turkey (IEIS): Turkish pharmaceutical manufacturers' association, representing an emerging-market pharma industry with comparable regulatory, pricing, and export ambitions to PPMA's members in Pakistan.
• Indian Pharmaceutical Alliance: Industry association representing large and mid-sized Indian pharmaceutical manufacturers — a directly analogous trade-body role to PPMA, but operating in India's much larger pharma market with significantly greater export and R&D scale.
• Organisation of Pharmaceutical Producers of India (OPPI): Indian pharma industry association that combines domestic manufacturers and multinational research-based companies. Comparable to PPMA in function (industry representation, policy advocacy) but serves a far more mature and globally integrated pharma sector.
• Bangladesh Association of Pharmaceutical Industries (BAPI): National trade body for Bangladesh's pharmaceutical manufacturers. Closest geographic and developmental-stage peer to PPMA, representing a similarly export-aspirational local pharma industry with comparable regulatory and policy-advocacy needs.

Emerging players

• Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA): South Korean trade body representing pharma and biopharma manufacturers. Comparable emerging-export-market profile to Pakistan, with stronger biologics capabilities — a useful benchmark for PPMA as Pakistani pharma attempts to move up the value chain.

Broad incumbents

• China Pharmaceutical Industry Association (CPIA): National-level industry body for China's pharmaceutical sector. Functions as a counterpart to PPMA in policy advocacy, but represents a vastly larger and globally significant pharma industry — also a direct partner organization through the Pakistan-China B2B Investment Conference.
• European Federation of Pharmaceutical Industries and Associations (EFPIA): European pharmaceutical industry umbrella body. Performs the same collective representation function as PPMA across EU member states; PPMA references EMA and EFPIA-style engagement as part of its international orientation.
• Japan Pharmaceutical Manufacturers Association (JPMA): Japan's leading pharmaceutical industry association representing research-driven manufacturers. Comparable in organizational role but operates in a far more advanced regulatory, R&D, and export-oriented environment than PPMA.
• Pharmaceutical Research and Manufacturers of America (PhRMA): US pharmaceutical industry association representing research-based biopharmaceutical companies. Analogous advocacy-and-policy role to PPMA but in a far larger, innovation-led market; PPMA explicitly references PhRMA as an international counterpart.

Others

• International Federation of Pharmaceutical Manufacturers & Associations (IFPMA): Global pharma industry federation. PPMA aligns itself with IFPMA-style international engagement (referencing WHO, FDA, and EMA as partner reference points), making IFPMA a thematic global peer rather than a direct domestic competitor.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/PPMAofficial.pk
• LinkedInlinkedin.com/company/pakistan-pharmaceutical-manufacturers-association
• Instagraminstagram.com/ppmaofficialpk
• Xx.com/PPMAofficial

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pakistan Pharmaceutical Manufacturing Association